US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

22.35

+0.08260.37%

Volume:3.18K

Turnover:69.08K

Market Cap:4.25M

PE:- -

High:22.39

Open:20.04

Low:20.01

Close:22.27

52wk High:43.73

52wk Low:19.00

Shares:190.00K

Float Shares:190.00K

Volume Ratio:1.13

T/O Rate:1.67%

Dividend:0.93

Dividend Rate:4.15%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Wegovy vs. Foundayo: Novo Nordisk’s “Record-Breaking” Run Meets the Eli Lilly (LLY) Challenge

Market Chatter: US Set to Impose 100% Tariffs on Some Drug Imports

MT Newswires Live

Why 2026 Is Biotech's Comeback Year -- Barrons.com

Novo Nordisk in focus as FDA approves Eli Lilly’s Foundayo

Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market

Analysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Novo Nordisk (NVO)

U.K. Healthcare System to Offer Novo Nordisk's Wegovy Shot to 1.2 Million Heart Patients

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan

Benzinga_recent_news

Mixed options sentiment in Novo Nordisk with shares up 2.45%

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

Novo Nordisk Launches Multi-Month Wegovy Subscription Program

MT Newswires Live

Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®

Scholar Rock Resubmits Biologics License Application for Apitegromab to US FDA

MT Newswires Live

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live

Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts -- Barrons.com

Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme

Novo Nordisk: Solid Wegovy Pill Uptake but Intensifying GLP‑1 Competition Keeps Shares at Hold

Novo Nordisk Earnings Could Be Solid, but Consensus Still Too High -- Market Talk

J.P. Morgan Remains a Hold on Novo Nordisk (0QIU)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NVOH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":22.3545,"timestamp":1776369600000,"preClose":22.2719,"halted":0,"volume":3176,"delay":0,"changeRate":0.003708709180626839,"floatShares":190001,"shares":190001,"eps":0,"marketStatus":"Pre-Mkt","change":0.0826,"latestTime":"04-17 05:33:14 EDT","open":20.04,"high":22.39,"low":20.01,"amount":69084.2,"amplitude":0.106861,"askPrice":35.76,"askSize":200,"bidPrice":8.99,"bidSize":100,"shortable":0,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776432600000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":22.3545,"nav":22.290632,"aum":4235242.370632,"dividendRate":0.041535,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.3545,"latestTime":"16:10 EDT","volume":6,"amount":134.127,"timestamp":1776370204125,"change":-0.0145,"changeRate":-0.000649,"amplitude":0},"volumeRatio":1.1277018859057786,"impliedVol":0.2556,"impliedVolPercentile":0.2727},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":190001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.1277018859057786,"shares":190001,"dividePrice":0.9285,"high":22.39,"amplitude":0.106861,"preClose":22.2719,"low":20.01,"week52Low":19,"pbRate":"--","week52High":43.73,"institutionHeld":0,"latestPrice":22.3545,"committee":-0.333333,"eps":0,"divideRate":0.041535,"volume":3176,"delay":0,"ttmEps":0,"open":20.04,"prevYearClose":27.4362,"prevWeekClose":20.6636,"prevMonthClose":20.5842,"prevQuarterClose":20.5842,"fiveDayClose":20.6683,"twentyDayClose":20.6,"sixtyDayClose":32.7865},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2624577086","title":"Wegovy vs. Foundayo: Novo Nordisk’s “Record-Breaking” Run Meets the Eli Lilly (LLY) Challenge","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624577086?lang=en_us&edition=fundamental","pubTime":"2026-04-02 17:51","pubTimestamp":1775123508,"startTime":"0","endTime":"0","summary":"Shares in Danish drugmaking giant Novo Nordisk ($NVO) — already down about 26% since the start of the year — are now facing even more pressure afte...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/foundayo-vs-wegovy-novo-nordisks-record-breaking-run-meets-the-eli-lilly-lly-challenge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/foundayo-vs-wegovy-novo-nordisks-record-breaking-run-meets-the-eli-lilly-lly-challenge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2112291526.USD","LU2063271972.USD","LU2211815571.USD","LU2756315664.SGD","SG9999018857.SGD","LU1064131342.USD","LU1548497426.USD","LU0256863902.USD","LU0820562030.AUD","LU0823416689.USD","LU2491050154.USD","IE00BJJMRZ35.SGD","LU0964807845.USD","LU1069344957.HKD","LU0640476718.USD","LU0058720904.USD","LU2111349929.HKD","LU2271345857.HKD","LU0106261372.USD","IE00BFSS7M15.SGD","IE00BKPKM429.USD","IE00BJT1NW94.SGD","SGXZ81514606.USD","LU2746668974.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","IE00BKVL7J92.USD","SG9999014906.USD","LLII","LU0432979614.USD","IE0001KFT4U8.USD","LU2468319806.SGD","LU0353189763.USD","LU2089984988.USD","LU1868837300.USD","LU2108987350.USD","SG9999015952.SGD","IE00BZ1G4Q59.USD","GB00BDT5M118.USD","LU0672654240.SGD","LU0823434740.USD","LU1366192091.USD","LU1551013425.SGD","LU0320765992.SGD","LU2028103732.USD","LU2168563687.JPY","LU2471134523.USD","LU1551013342.USD","LU2361045086.USD","IE00B4JS1V06.HKD","LU2461242641.AUD","LU2750360997.AUD","LU0708995401.HKD","LU0266013472.USD","LU2168564149.EUR","LU2746668461.USD","LU0203202063.USD","NVO","LU0417517546.SGD","LU0210536198.USD","LU0256863811.USD","LU1267930730.SGD","LU2089284900.SGD","LU1323610961.USD","LU2168564222.USD","LU2168564495.EUR","SG9999015978.USD","LU0820561909.HKD","IE00B7KXQ091.USD","LU2361044949.HKD","IE00B775H168.HKD","LU0122379950.USD","LU2552382215.SGD","LU2236285917.USD","IE0004445239.USD","LU2462157665.USD","BK4581","LU2361044865.SGD","LU1232071149.USD","LU1988902786.USD","IE00BKDWB100.SGD","LU2264538146.SGD","LU0154236417.USD","SG9999013999.USD","SG9999018865.SGD","LU0823434583.USD","LU1127390331.HKD","LU2491050071.SGD","LU0097036916.USD","LU0456855351.SGD","IE00BN29S564.USD","BK4532","LU0316494557.USD","LU1623119135.USD","SG9999015986.USD","IE00BJJMRY28.SGD","LU0109394709.USD","LU2237443465.HKD","SG9999014880.SGD","LU0158827948.USD","LU0786609619.USD","LU0353189680.USD","LU0079474960.USD","BK4007","LU2357305700.SGD","LU2237438978.USD","SGXZ31699556.SGD","LU0006306889.USD","LU1023059063.AUD","LU2023250504.SGD","LU2023251221.USD","LU2237443549.SGD","LU0354030511.USD","LU1983299246.USD","LU2552382058.USD","LU2089283258.USD","LU0096364046.USD","LU2237443382.USD","NVOH","LU2417539215.USD","IE00BWXC8680.SGD","LLYX","LU2087625088.SGD","LU2471134879.HKD","LU2471134952.CNY","IE00BJLML261.HKD","LU1989771016.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0289739699.SGD","LU1868836591.USD","IE00BJJMRX11.SGD","SGXZ99366536.SGD","BK4534","IE0005OL40V9.USD","LU0943347566.SGD","LU2552382132.HKD","LU1868837136.USD","LU0385154629.USD","LU2237443895.HKD","IE0002141913.USD","ELIL","LU1974910355.USD","LU0683600562.USD","SG9999014914.USD","IE00BFSS8Q28.SGD","LU0198837287.USD","LU0238689110.USD","LU1093756325.SGD","IE00B2B36J28.USD","LU1629891620.HKD","LU0225283273.USD","LU0471298694.HKD","BK4599","LU1868836757.USD","BK4516","LU2471134796.USD","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU1720051108.HKD","LLYZ","SG9999015945.SGD","LU2265009873.SGD","LU0882574139.USD","LU1145028129.USD","LU1868836914.USD","LU1035775433.USD","IE0004445015.USD","LU1814569148.SGD","LU0820561818.USD","LU1712237335.SGD","LU2491049909.HKD","LU0466842654.USD","LU0889565916.HKD","LU1291159041.SGD","LU2602419157.SGD","IE0009355771.USD","LU0689472784.USD","SG9999014898.SGD","LU2750360641.GBP","LU2106854487.HKD","LU0114720955.EUR","LU2756315318.SGD","LU2360106947.USD","LU0882574055.USD","SG9999017495.SGD","BK4588","BK4533","LU1093756168.USD","LU1917777945.USD","BK4585","LU2237443622.USD","LU1804176565.USD","LU0094547139.USD","SGXZ51526630.SGD","LU2168564065.EUR","LU2456880835.USD","IE00B1BXHZ80.USD","LU0234572021.USD","LU1280957306.USD","SG9999001176.SGD","LU0320765059.SGD","LU0471298777.SGD","LU0323591593.USD","LU1057294990.SGD","LU2324357040.USD","NVOX","LU2237443978.SGD","LU0061475181.USD","ELIS","LU2023250330.USD","IE00BK4W5L77.USD","LU0109391861.USD","LU0158827781.USD","IE00B4R5TH58.HKD","LU1061106388.HKD","LU0203201768.USD","LU0354030438.USD","LU0787776722.HKD","IE00BK4W5M84.HKD","LLY","LU2896262040.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624795572","title":"Market Chatter: US Set to Impose 100% Tariffs on Some Drug Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=2624795572","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624795572?lang=en_us&edition=fundamental","pubTime":"2026-04-02 17:34","pubTimestamp":1775122490,"startTime":"0","endTime":"0","summary":"The US is set to impose 100% tariffs on certain imported medicines as part of an attempt to pressure pharmaceutical firms to shift production to the US, the Financial Times reported Thursday, citing people familiar with the matter.The levies, which are set to be announced Thursday, apply to imports from companies and countries that have yet to strike deals with the White House, the report said.The European Union, the UK, Pfizer , AstraZeneca , and Novo Nordisk  are among those that have worked out deals for lower tariffs, the report said.The White House did not immediately reply to MT Newswires' request for comment.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1804176565.USD","IE00BLSP4239.USD","LU0787776722.HKD","LU2089284900.SGD","SG9999011175.SGD","LU0965508806.USD","LU0786609619.USD","LU0069063385.USD","LU1732799900.SGD","LU1868836757.USD","LU0868494617.USD","LU0708995401.HKD","LU1196500208.SGD","LU2360106947.USD","LU0211331839.USD","LU0354030511.USD","LU2236285917.USD","LU0306807586.USD","IE00BKDWB100.SGD","LU0058720904.USD","ELIS","LU0823416689.USD","LU2746668461.USD","LU1035775433.USD","LU0472753341.HKD","SG9999015945.SGD","LU2087621335.USD","LU2592432038.USD","IE00B4R5TH58.HKD","LU1032466523.USD","LLYX","BK4592","SG9999018857.SGD","BK4588","LU1267930490.SGD","IE00B1XK9C88.USD","LU2471134952.CNY","LU0320765646.SGD","LU1571399168.USD","IE00B1BXHZ80.USD","LU2264538146.SGD","IE00B7KXQ091.USD","IE00BJJMRX11.SGD","LU1066053197.SGD","LU0238689110.USD","LU2129689431.USD","BK4139","IE0034235303.USD","LU1551013342.USD","IE00BJJMRY28.SGD","LU1929549753.HKD","BK4532","LU2417539215.USD","LLII","SG9999014914.USD","LU0456855351.SGD","LU0942090050.USD","LU1221951046.USD","LU2360032135.SGD","LU0965509283.SGD","IE0001KFT4U8.USD","IE00BZ1G4Q59.USD","LU1116320737.USD","LU0203201768.USD","LU2265009873.SGD","IE00BFSS7M15.SGD","LU0198837287.USD","LU2750360641.GBP","LU0203347892.USD","LU2552382215.SGD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0943347566.SGD","BK4599","LU2023250843.SGD","LU0868494708.USD","LU0320765489.SGD","LU1037948897.HKD","LU1366192091.USD","LU2491050154.USD","LU0256863811.USD","LU2462157665.USD","SG9999018865.SGD","LU1261432733.SGD","IE00B3T34201.USD","LU0203202063.USD","LU0124676726.USD","SG9999017495.SGD","LU0545039389.USD","SG9999014559.SGD","LU1989771016.USD","LU1267930730.SGD","LU0965509101.SGD","LU0994945656.USD","LU1989772840.SGD","IE00B2B36J28.USD","IE000M9KFDE8.USD","LU0553294199.USD","ELIL","LU2750360997.AUD","IE00BFSS8Q28.SGD","LU0070302665.USD","LU0466842654.USD","LU2112291526.USD","LU0426412945.USD","LU0689626769.HKD","LU1732800096.USD","IE00B775H168.HKD","SG9999014880.SGD","LU1121112475.USD","LU0823434583.USD","LU2430703095.HKD","LU0985320562.USD","LU0109391861.USD","SG9999014906.USD","LU2461242641.AUD","LU0511384066.AUD","LU0320765059.SGD","LU0345770993.USD","LU2168564495.EUR","LU2237443622.USD","LU2505996509.AUD","LU2111349929.HKD","LU0426417589.USD","LU0128525929.USD","LU0234570918.USD","IE00BGHQF631.EUR","IE00BFXG1179.USD","LU1974910355.USD","LU2087625088.SGD","IE0002141913.USD","IE00BN29S564.USD","LU1934455863.HKD","LU1548497426.USD","LU0210536198.USD","LU0648001328.SGD","LU0203345920.USD","LU1061106388.HKD","LU0289739699.SGD","LU2746668974.SGD","LU2491050071.SGD","LU2324357040.USD","LU2063271972.USD","LU0964807845.USD","LU0225284248.USD","LU0861579265.USD","LU0354030438.USD","LU0265550359.USD","LU2361044865.SGD","LU2602419157.SGD","LU1829250122.USD","IE00BJT1NW94.SGD","LU0965509010.AUD","LU2129689514.USD","LU1720051017.SGD","LU1988902786.USD","LU2471134523.USD","LU0882574055.USD","LU1699723380.USD","LU1145028129.USD","LU0471298777.SGD","LU0417517546.SGD","LU1623119135.USD","BK4559","LU1674673691.USD","LU1267930573.SGD","LU0208291251.USD","LU0432979614.USD","LU2357305700.SGD","SG9999015341.SGD","LU0154236417.USD","IE0009355771.USD","LU1934455277.USD","LU2211815571.USD","LU0477156953.USD","LU2168563687.JPY","LU0079474960.USD","LU0096364046.USD","NVOH","NVOX","SG9999015986.USD","LU0158827948.USD","LU2756315318.SGD","LU0738911758.USD","LU1935042991.SGD","LU0345769128.USD","LU1983299246.USD","LU0211327993.USD","LU1116320901.HKD","BK4568","LU1868836914.USD","LU0321505439.SGD","IE00BKVL7J92.USD","LU0310799852.SGD","LU2756315664.SGD","LU0385154629.USD","LU2125154935.USD","LU0320765992.SGD","SG9999014542.SGD","IE00BVYPNW00.USD","LU0795875086.SGD","LU2347655156.SGD","LU0345769631.USD","LU0098860793.USD","LU2237443978.SGD","LU0266013472.USD","LU0130102774.USD","LU1883839398.USD","LU2237443382.USD","LU2552382132.HKD","NVO","IE0004445239.USD","PFE","LU2468319806.SGD","LU1059921491.USD","LU0882574139.USD","LU0289739343.SGD","LU0353189680.USD","LU1323610961.USD","LU1037948541.HKD","BK4007","LU0109394709.USD","LU2237443465.HKD","LU0114720955.EUR","LU1989772923.USD","SG9999015978.USD","LU0006306889.USD","LU0640476718.USD","LU1244550221.USD","IE00BLSP4452.SGD","IE00BSNM7G36.USD","IE00BK4W5M84.HKD","LU0323591593.USD","LU2089283258.USD","BK4581","LU0097036916.USD","LU2028103732.USD","SG9999002224.SGD","IE00BDGV0183.EUR","LU0170899867.USD","LU0234572021.USD","SG9999003800.SGD","LU1674673428.USD","LU1585245621.USD","SG9999015358.SGD","LU2361045086.USD","IE00B4JS1V06.HKD","AZN","LU1868836591.USD","LU1291159041.SGD","LU0158827781.USD","LU1023059063.AUD","LU0130517989.USD","LU2456880835.USD","LU0708994859.HKD","LU2237443895.HKD","LU0310800379.SGD","LU1551013425.SGD","BK4516","BK4504","LU2023251221.USD","LU2505996681.GBP","IE00BVYPNV92.GBP","LU0823434740.USD","LU1035773651.USD","LU0471298694.HKD","LU0106261372.USD","IE00BBT3K403.USD","SG9999014898.SGD","LU0306806265.USD","LU1066051498.USD","LU0094547139.USD","LU0683600562.USD","BK7095","LU2213496289.HKD","LU2471134796.USD","LU2168564065.EUR","LU2430703251.USD","SG9999002232.USD","LU1934455194.USD","LU1506573853.SGD","LU0689472784.USD","LU0820562030.AUD","LU0345770308.USD","LU0820561818.USD","LU1778281490.HKD","LU2023250330.USD","LU1162221912.USD","LU1718418525.SGD","LU1066051811.HKD","BK4550","IE00BJLML261.HKD","LU2552382058.USD","LLYZ","LU2896262040.SGD","LU0225771236.USD","IE00BJJMRZ35.SGD","LU1069347547.HKD","LU1093756168.USD","LU2237438978.USD","BK4585","LU0057025933.USD","LU0211328371.USD","LU2129689605.HKD","LU1712237335.SGD","LU1232071149.USD","LU1003077747.HKD","LU1941712348.USD","SGXZ51526630.SGD","LU0321505868.SGD","LU1496350171.SGD","LU1066051225.USD","LU1267930813.SGD","BK4566","LU1496350502.SGD","LU2023250504.SGD","LU1057294990.SGD","LU1914381329.SGD","LU1868837136.USD","LU1032955483.USD","LU0061475181.USD","LU1720051108.HKD","SGXZ57979304.SGD","LU2089984988.USD","SGXZ31699556.SGD","LU1221951129.SGD","LU2361044949.HKD","LU1069344957.HKD","LU2125154778.USD","LU1894683264.USD","LU0256863902.USD","LU0820561909.HKD","LU1917777945.USD","IE00B42XCP33.USD","LU1814569148.SGD","LU2471134879.HKD","IE00B19Z3581.USD","LU0795875169.SGD","LU1839511570.USD","SG9999001176.USD","LU1043141123.HKD","LU1629891620.HKD","IE00B3PB1722.GBP","SG9999001176.SGD","LU2168564149.EUR","BK7104","SGXZ99366536.SGD","LU0672654240.SGD","LU2168564222.USD","LU1894683348.USD","LU1074936037.SGD","LU2108987350.USD","LU2271345857.HKD","LU0225283273.USD","SG9999014567.USD","LU1430594728.SGD","BK4533","IE00BK4W5L77.USD","GB00BDT5M118.USD","LU0265550946.USD","LU0980610538.SGD","LU1868837300.USD","LU0661504455.SGD","SG9999001440.SGD","IE00BN8TJ469.HKD","SG9999013999.USD","IE0005OL40V9.USD","LU1201861249.SGD","LU0889565916.HKD","LU0792757196.USD","LU1127390331.HKD","LU2133065610.SGD","IE00B7SZLL34.SGD","IE00BKPKM429.USD","LU1244550494.USD","LU1280957306.USD","IE0002270589.USD","LU0316494557.USD","LU0912757837.SGD","LU0985481810.HKD","LU1093756325.SGD","LU2491049909.HKD","IE00BWXC8680.SGD","LU2430703178.SGD","SG9999014575.USD","LU2106854487.HKD","LU1244550577.SGD","SGXZ81514606.USD","LU1043141396.HKD","LU1064131342.USD","LU0889566641.SGD","LU0353189763.USD","LU0949170772.SGD","IE0004445015.USD","SG9999015952.SGD","LU0122379950.USD","LU0289961442.SGD","BK4534","LU0070217475.USD","LU1941712264.USD","LU2237443549.SGD","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624054992","title":"Why 2026 Is Biotech's Comeback Year -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2624054992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624054992?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:07","pubTimestamp":1775074020,"startTime":"0","endTime":"0","summary":"About the author:  Nilesh Kumar is head of biotech private investments at Wellington Management.As pharmaceutical companies raced to develop a Covid-19 vaccine in 2020, the biotech industry boomed. Investors eager to capitalize on the momentum poured money into biotech companies and sought opportunities to back new drugs, regardless of where they were on the path to clinical success and regulatory approval.At the peak of the biotech boom in 2021, more than half of the 104 companies that went public in the U.S. were either preclinical or in Phase 1 trials -- the earliest stages of testing for new medicines -- and therefore the most speculative stage from an investment standpoint. By 2024, the number of new offerings had dwindled to 24. Last year, only 11 biotech companies joined the market. Just one was a company whose leading drug candidate was in early-stage trials.The launch in January of the first oral obesity drug by Novo Nordisk was the beginning of several new obesity treatments ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ81514606.USD","LU1232071149.USD","LU1868836757.USD","LU2417539215.USD","LU2461242641.AUD","SG9999018857.SGD","AMGN","BK4599","BK4585","LU0823434583.USD","BK4007","IE000M9KFDE8.USD","IE00BK4W5L77.USD","LU0203202063.USD","LU2108987350.USD","LU0238689110.USD","LU2552382215.SGD","LU1548497426.USD","LU1066051498.USD","LU0114720955.EUR","LU2471134952.CNY","LU2168564149.EUR","LU1894683264.USD","SG9999002224.SGD","BK4581","LU1127390331.HKD","LU1629891620.HKD","LU2237443382.USD","LU2237443465.HKD","LU2552382132.HKD","LU0225283273.USD","LU2756315664.SGD","LU0256863902.USD","IE00B775H168.HKD","IE00BJT1NW94.SGD","LU0094547139.USD","BK4534","LU2471134879.HKD","PFE","IE00BKVL7J92.USD","IE00B2B36J28.USD","XBI","LU1291159041.SGD","LU1894683348.USD","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU0158827948.USD","LU2168564495.EUR","LU2023251221.USD","LU2236285917.USD","GB00BDT5M118.USD","LU0820562030.AUD","IE0002141913.USD","BK4568","LU2491050154.USD","LU1988902786.USD","SG9999018865.SGD","LU0079474960.USD","LU1267930730.SGD","LU2237438978.USD","LU2265009873.SGD","LU2237443978.SGD","LU2750360997.AUD","LU0964807845.USD","BK4139","SG9999014906.USD","NVOH","LU2063271972.USD","LU2111349929.HKD","LU0417517546.SGD","LU0466842654.USD","LU2361044949.HKD","LU2112291526.USD","LU2750360641.GBP","BK4588","IE00B4JS1V06.HKD","LU1069344957.HKD","LU1551013342.USD","LU1093756168.USD","SG9999015986.USD","SG9999015945.SGD","LLII","LU0097036916.USD","LU0158827781.USD","IE00BN29S564.USD","LU1720051017.SGD","LU2746668974.SGD","SG9999015952.SGD","LU0672654240.SGD","LU2168564222.USD","NVO","LU2471134796.USD","LU2242652126.USD","SG9999017495.SGD","LU0109394709.USD","LU0154236417.USD","ELIS","LU2028103732.USD","LU0882574139.USD","LU0198837287.USD","LU0471298777.SGD","LU0385154629.USD","LU0320765992.SGD","LU2491050071.SGD","LU2468319806.SGD","IE0001KFT4U8.USD","IE00BJJMRY28.SGD","LU0321505868.SGD","LU1023059063.AUD","LU2462157665.USD","IE0004445239.USD","BK4550","IE0009355771.USD","LU1814569148.SGD","LU2361045086.USD","IE00B1XK9C88.USD","LU0321505439.SGD","SG9999014880.SGD","LU0456855351.SGD","LU1868837300.USD","LU2602419157.SGD","LU1064131342.USD","LU0820561909.HKD","LU2896262040.SGD","LU1066053197.SGD","LU2089283258.USD","LLYZ","LU2089284900.SGD","LU0106261372.USD","LU0266013472.USD","LU0109391861.USD","04332","LU2211815571.USD","LU0787776722.HKD","LU0823434740.USD","IE00BJLML261.HKD","LU1989771016.USD","LU0985481810.HKD","LU0820561818.USD","LU1571399168.USD","LU0234572021.USD","LU0353189763.USD","LU1983299246.USD","LU0316494557.USD","SG9999015978.USD","IE00BLSP4452.SGD","LU0006306889.USD","LU2361044865.SGD","LU0306807586.USD","LU1883839398.USD","LU0471298694.HKD","LU0320765059.SGD","LU0786609619.USD","LU2357305700.SGD","LU2471134523.USD","LU2237443895.HKD","LLY","IE00BFSS7M15.SGD","LU1145028129.USD","SG9999002232.USD","IE0004445015.USD","LU0170899867.USD","BK4533","LLYX","LU1280957306.USD","LU2106854487.HKD","IE00BWXC8680.SGD","LU0225771236.USD","LU1323610961.USD","LU2168563687.JPY","LU2271345857.HKD","BK4532","IE00BKPKM429.USD","SG9999003800.SGD","LU1720051108.HKD","LU1917777945.USD","LU2746668461.USD","SGXZ51526630.SGD","LU0432979614.USD","LU1804176565.USD","LU0943347566.SGD","IE00BK4W5M84.HKD","LU1712237335.SGD","IE00BLSP4239.USD","LU1061106388.HKD","LU0354030511.USD","LU2242646821.SGD","LU2087625088.SGD","BK4516","IE00BJJMRX11.SGD","LU1868836914.USD","LU2023250504.SGD","SG9999011175.SGD","LU0889565916.HKD","LU2264538146.SGD","LU0203201768.USD","IE00BZ1G4Q59.USD","SGXZ31699556.SGD","SGXZ57979304.SGD","LU2213496289.HKD","IE0005OL40V9.USD","LU0882574055.USD","BK4592","LU0683600562.USD","BK4566","SG9999001176.USD","LU2360106947.USD","IE00BKDWB100.SGD","LU1366192091.USD","IE00B1BXHZ80.USD","IE00B7KXQ091.USD","LU0323591593.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2552382058.USD","LU2456880835.USD","LU1551013425.SGD","LU2237443549.SGD","LU0058720904.USD","SGXZ99366536.SGD","ELIL","LU1035775433.USD","LU0306806265.USD","LU0289739699.SGD","LU0353189680.USD","LU2756315318.SGD","LU0708995401.HKD","LU0640476718.USD","LU2023250330.USD","IE00BFTCPJ56.SGD","LU2491049909.HKD","LU0354030438.USD","LU1974910355.USD","SG9999014914.USD","LU0225284248.USD","LU0210536198.USD","SG9999013999.USD","LU2089984988.USD","IE0002270589.USD","LU1623119135.USD","LU1868836591.USD","LU2237443622.USD","SG9999014898.SGD","LU0689472784.USD","LU2324357040.USD","SG9999001176.SGD","LU0868494617.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU1868837136.USD","LU0096364046.USD","NVOX","SG9999001440.SGD","LU2168564065.EUR","IE00B19Z3B42.SGD","LU1093756325.SGD","LU0061475181.USD","LU0256863811.USD","LU0122379950.USD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624044510","title":"Novo Nordisk in focus as FDA approves Eli Lilly’s Foundayo","url":"https://stock-news.laohu8.com/highlight/detail?id=2624044510","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624044510?lang=en_us&edition=fundamental","pubTime":"2026-04-02 00:10","pubTimestamp":1775059817,"startTime":"0","endTime":"0","summary":"Shares of Novo Nordisk (NVO) are in focus at midday after the Food and Drug Administration approved Eli Lilly’s (LLY) GLP-1 pill. Eli Lilly announc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-in-focus-as-fda-approves-eli-lillys-foundayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"fde9ba938e2947ed6fe3093795cd4028","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-in-focus-as-fda-approves-eli-lillys-foundayo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2552382215.SGD","NVO","LU0466842654.USD","LU2087625088.SGD","LU0097036916.USD","SGXZ31699556.SGD","LU2168564149.EUR","ELIL","LU2461242641.AUD","LU0198837287.USD","LU0114720955.EUR","LU0154236417.USD","LU1093756168.USD","LU2168564222.USD","SG9999018857.SGD","IE00BK4W5L77.USD","LU1366192091.USD","LU2023251221.USD","LU2896262040.SGD","LU0096364046.USD","LU1868837300.USD","LU1551013425.SGD","LU2456880835.USD","LU1035775433.USD","IE00BFSS7M15.SGD","LU2552382132.HKD","LU0058720904.USD","LU2168564495.EUR","SGXZ51526630.SGD","LU0006306889.USD","LU1551013342.USD","IE0001KFT4U8.USD","LU1280957306.USD","LU1988902786.USD","LU0708995401.HKD","LU2063271972.USD","LU2361044949.HKD","LU2552382058.USD","LU1232071149.USD","SG9999001176.USD","LU2237443382.USD","LU1868836591.USD","BK4532","LU2028103732.USD","LU2417539215.USD","LU0256863811.USD","LU0106261372.USD","SG9999014914.USD","LU2471134879.HKD","SG9999017495.SGD","LU0266013472.USD","LU0823434740.USD","LU1814569148.SGD","LU2168564065.EUR","LU2471134952.CNY","SG9999013999.USD","LU0354030438.USD","LU2089984988.USD","LU2264538146.SGD","LU1069344957.HKD","LU2236285917.USD","LU2271345857.HKD","ELIS","LU1291159041.SGD","BK4534","LU0787776722.HKD","BK4585","LU2468319806.SGD","IE00BKVL7J92.USD","SG9999015978.USD","LU2237443895.HKD","LU2265009873.SGD","LU0943347566.SGD","IE00BZ1G4Q59.USD","LU0320765059.SGD","LU0234572021.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0225283273.USD","LU2361044865.SGD","BK4516","SG9999015986.USD","SG9999001176.SGD","LU2089284900.SGD","LU1064131342.USD","LU1057294990.SGD","LU1127390331.HKD","LU0158827948.USD","IE00BJJMRZ35.SGD","LLYX","LU2462157665.USD","LLYZ","IE00BKPKM429.USD","LU1868836757.USD","IE0005OL40V9.USD","LU0385154629.USD","LU2750360641.GBP","LU0456855351.SGD","LU2602419157.SGD","LU2237438978.USD","LU1623119135.USD","LU2756315664.SGD","SGXZ99366536.SGD","IE00B4JS1V06.HKD","SG9999014898.SGD","LU0689472784.USD","SG9999014880.SGD","LU0823434583.USD","LU2746668461.USD","LU2746668974.SGD","LU0683600562.USD","LU0094547139.USD","LU1629891620.HKD","LU1712237335.SGD","IE00BJJMRX11.SGD","LU0820562030.AUD","LU2023250330.USD","LU2168563687.JPY","LU2491050154.USD","IE0009355771.USD","LU2491049909.HKD","SG9999015952.SGD","LU0289739699.SGD","LU0203201768.USD","NVOX","LU0203202063.USD","IE00BK4W5M84.HKD","IE00BN29S564.USD","LU0238689110.USD","IE00BKDWB100.SGD","LU2023250504.SGD","LU0471298777.SGD","BK4533","LU1720051017.SGD","LU2471134796.USD","LU1868836914.USD","IE00B2B36J28.USD","BK4599","LU1093756325.SGD","LU2324357040.USD","BK4588","LU1804176565.USD","SGXZ81514606.USD","LU2360106947.USD","IE0004445239.USD","LU0823416689.USD","LU0786609619.USD","IE00BJT1NW94.SGD","LU2237443465.HKD","LU2237443622.USD","LU0316494557.USD","IE00BJLML261.HKD","LU1974910355.USD","NVOH","LU0882574139.USD","LU2357305700.SGD","LU2237443978.SGD","LU0256863902.USD","LU1983299246.USD","LU1989771016.USD","LLII","LU0109391861.USD","GB00BDT5M118.USD","LU0820561818.USD","LU2237443549.SGD","LU0079474960.USD","LU1917777945.USD","LU2089283258.USD","LU1323610961.USD","LU0158827781.USD","IE00BFTCPJ56.SGD","SG9999018865.SGD","LU0210536198.USD","LU0964807845.USD","LU2106854487.HKD","LU2491050071.SGD","LU2111349929.HKD","LU1548497426.USD","IE00BFSS8Q28.SGD","LU0640476718.USD","IE00BJJMRY28.SGD","LU0354030511.USD","LU0820561909.HKD","LU1720051108.HKD","LU2361045086.USD","SGXZ57979304.SGD","LU2112291526.USD","LU2471134523.USD","LU0353189680.USD","BK4007","BK4581","LU0353189763.USD","LU0320765992.SGD","LU1145028129.USD","LU2108987350.USD","LU2213496289.HKD","LU0432979614.USD","LU0882574055.USD","IE0002141913.USD","LU1023059063.AUD","LU1267930730.SGD","SG9999015945.SGD","LLY","LU0323591593.USD","LU0672654240.SGD","LU1061106388.HKD","LU2756315318.SGD","IE0004445015.USD","LU0471298694.HKD","LU1868837136.USD","IE00B775H168.HKD","IE00B7KXQ091.USD","LU0417517546.SGD","LU2211815571.USD","IE00B1XK9C88.USD","SG9999014906.USD","LU0109394709.USD","LU2750360997.AUD","LU0889565916.HKD","LU0061475181.USD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624510951","title":"Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2624510951","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624510951?lang=en_us&edition=fundamental","pubTime":"2026-04-02 00:02","pubTimestamp":1775059320,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S advanced 2.6% to DKK236.90 Wednesday on what proved to be an overall favorable trading session for the stock market, with the OMX Nordic 40 Index rising 3.0% to 2,467.54.The company closed DKK296.50 short of its 52-week high of DKK533.40, which the company reached on June 13, 2025.Trading volume was 6,640,376, compared to the 50-day average trading volume of 8,866,822.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":[".DJI","BK4585","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756168.USD","NVOH","NVOX","IE00BZ1G4Q59.USD","NVO","DJX","LU1093756325.SGD","BK4532","BK4007","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624379511","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Imunon (IMNN) and Novo Nordisk (NVO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624379511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624379511?lang=en_us&edition=fundamental","pubTime":"2026-04-01 21:30","pubTimestamp":1775050208,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Imunon (IMNN) and Novo Nordisk (NVO). Imunon (IMNN) Alliance Glob...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-imunon-imnn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-imunon-imnn-and-novo-nordisk-nvo-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","NVO","LU0128526141.USD","IE00BZ1G4Q59.USD","BK4599","NVOX","LU0029874061.USD","BK4532","LU1093756168.USD","BK4137","IMNN","XBI","BK4588","BK4139","BK4585","BK4007","IE00BKVL7J92.USD","NVOH","BK4581","LU1093756325.SGD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624560208","title":"U.K. Healthcare System to Offer Novo Nordisk's Wegovy Shot to 1.2 Million Heart Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2624560208","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624560208?lang=en_us&edition=fundamental","pubTime":"2026-04-01 15:25","pubTimestamp":1775028300,"startTime":"0","endTime":"0","summary":"The U.K.'s state-run healthcare system will offer Novo Nordisk's Wegovy weight-loss shot to over a million patients in England to help prevent heart attacks and strokes.The decision comes after the country's independent health watchdog on Wednesday approved the drug for adults who have previously had a heart attack, stroke, or serious circulation problem in the legs, and who have a body mass index of at least 27.The National Institute for Health and Care Excellence  said that evidence from a clinical trial shows the injection reduces the risk of a heart attack, stroke, or cardiovascular death, with the benefit seen before significant weight loss occurred. This suggests the drug works directly on the heart and blood vessels, not just through weight loss, it said.\"We know that people who have already had a heart attack or stroke are living with real fear that it could happen again,\" said Helen Knight, director of medicines evaluation at NICE.NICE said around 1.2 million people across Eng","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BK4543","IE00BZ1G4Q59.USD","LABU","BK4599","BK4007","LU1093756168.USD","IE00BKVL7J92.USD","BK4566","BK4581","LU1093756325.SGD","NVO","BK4137","BK4023","BK4532","IE00BFMHRM44.USD","LU0154236417.USD","BK4585","LU0029874061.USD","LU0128526141.USD","NVOH","XBI","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624349635","title":"Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2624349635","media":"Benzinga_recent_news","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624349635?lang=en_us&edition=fundamental","pubTime":"2026-04-01 02:35","pubTimestamp":1774982100,"startTime":"0","endTime":"0","summary":"Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro, WeightWatchers, LifeMD, and more.","market":"sh","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/31/Wegovy.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/31/Wegovy.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51579939/slash-your-wegovy-costs-novo-nordisk-reveals-first-ever-subscription-plan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51579939/slash-your-wegovy-costs-novo-nordisk-reveals-first-ever-subscription-plan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","IE00BKVL7J92.USD","NVOH","NVOX","LU1093756168.USD","NVO","BK4532","LU1093756325.SGD","LU0154236417.USD","BK4588","IE00BZ1G4Q59.USD","BK4585","BK4599"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623538608","title":"Mixed options sentiment in Novo Nordisk with shares up 2.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623538608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623538608?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:31","pubTimestamp":1774967489,"startTime":"0","endTime":"0","summary":"Mixed options sentiment in Novo Nordisk (NVO), with shares up 86c, or 2.45%, near $36.16. Options volume roughly in line with average with 18k cont...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-45-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mixed-options-sentiment-in-novo-nordisk-with-shares-up-2-45-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4588","BK4599","BK4585","BK4532","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","NVOH","LU0154236417.USD","LU1093756168.USD","LU1093756325.SGD","NVO","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623584882","title":"LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2623584882","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623584882?lang=en_us&edition=fundamental","pubTime":"2026-03-31 20:45","pubTimestamp":1774961100,"startTime":"0","endTime":"0","summary":"Delivering up to $1,200 in annual patient savings on branded GLP-1 therapy, expanding LifeMD’s collaboration with Novo NordiskNEW YORK, March  31, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD),","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3265539/6480/en/LifeMD-Offers-Novo-Nordisk-s-Industry-First-Wegovy-Telehealth-Subscription-Program.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","BK4007","IE00BKVL7J92.USD","NVOH","NVOX","LU0154236417.USD","LU1093756325.SGD","NVO","BK4585","BK4588","LFMD","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623058697","title":"Novo Nordisk Launches Multi-Month Wegovy Subscription Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2623058697","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623058697?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:55","pubTimestamp":1774958124,"startTime":"0","endTime":"0","summary":"Novo Nordisk Launches Multi-Month Wegovy Subscription Program","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ea115adc665c74e6a4a5582f9333b9fe","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU1093756325.SGD","BK4599","NVOH","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4532","NVOX","LU1093756168.USD","NVO","IE00BKVL7J92.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623586982","title":"Weight Watchers Announces Best in Market Self-Pay Wegovy® Pricing for Med+ Members and the Launch of Preferred Subscription Pricing for Wegovy via NovoCare®","url":"https://stock-news.laohu8.com/highlight/detail?id=2623586982","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623586982?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:49","pubTimestamp":1774957740,"startTime":"0","endTime":"0","summary":"Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight Wat","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/31/3265364/0/en/Weight-Watchers-Announces-Best-in-Market-Self-Pay-Wegovy-Pricing-for-Med-Members-and-the-Launch-of-Preferred-Subscription-Pricing-for-Wegovy-via-NovoCare.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BK4588","BK4585","LU1093756325.SGD","LU0154236417.USD","NVOX","BK4007","BK4599","NVO","NVOH","IE00BZ1G4Q59.USD","BK4192","WW","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623858637","title":"Scholar Rock Resubmits Biologics License Application for Apitegromab to US FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2623858637","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623858637?lang=en_us&edition=fundamental","pubTime":"2026-03-31 19:47","pubTimestamp":1774957669,"startTime":"0","endTime":"0","summary":"Scholar Rock  said Tuesday it has resubmitted to the US Food and Drug Administration the biologics license application for apitegromab as a treatment for children and adults with spinal muscular atrophy.The company said the resubmitted application followed the FDA's complete response letter in September 2025, which raised issues related to a facility of Catalent Indiana, which is a part of Novo Nordisk .Scholar Rock said the FDA has not requested additional corrective actions for the facility and that it has included a second US-based facility in the revised application to support the drug candidate's supply chain.The company said it expects the target action date in late September.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1093756325.SGD","SRRK","BK7104","BK4139","NVOX","BK4588","BK4532","LU1093756168.USD","NVOH","BK4007","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","IE00BKVL7J92.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623342264","title":"Novo Nordisk A/S Stock Rises Monday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2623342264","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623342264?lang=en_us&edition=fundamental","pubTime":"2026-03-31 00:03","pubTimestamp":1774886580,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S rose 1.2% to DKK231.15 Monday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 0.9% to 2,377.71.The company closed DKK302.25 below its 52-week high of DKK533.40, which the company achieved on June 13, 2025.Trading volume was 5,643,821, compared to the 50-day average trading volume of 8,889,345.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","NVOH","LU0154236417.USD","BK4007","BK4532","BK4585","NVOX","NVO","BK4588","BK4599","LU1093756325.SGD","LU1093756168.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623341038","title":"European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2623341038","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623341038?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:07","pubTimestamp":1774883261,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary kicked off the week higher late Monday morning, rising 0.78% to 1,700.55 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by petroleum refiner Equinor  and internet advertising firm Criteo , which rose 3.8% and 3.4%, respectively. They were followed by software firm SAP  and pharmaceutical company Novo Nordisk , which were up 1.4% each.The decliners from continental Europe were led by medical device maker EDAP TMS  and biopharmaceutical company Cellectis , which dropped 2.8% and 2.5%, respectively. They were followed by accommodations booking company trivago  and biotech firm BioNTech , which lost 1.8% and 0.4%, respectively.The gainers from the UK were led by pharmaceutical company AstraZeneca , which advanced by 2.9%. It was followed by pharmaceutical company Silence Therapeutics  and utilities company National Grid , which increased 2.4% and 2.3%, respectively.The decliners from the UK and Irel","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","BK4505","EQNR","BK4613","NVOH","LU2417539215.USD","EDAP","CLLS","TRVG","WPP.AU","LU2462157665.USD","SAP","BK4588","SLN","AFG","NVO.AU","BK4023","BK4117","NGG","CRTO","BK4585","LU0058720904.USD","BK4077","LU0154236417.USD","BK4548","BK4107","BK4009","LU2456880835.USD","BNTX","BK4532","IE00BKVL7J92.USD","IHG","BK4208","LU0109394709.USD","BK4599","NVOX","IE00BFMHRM44.USD","BK4201","MREO","BK4007","IE00BZ1G4Q59.USD","AMRN","IE00B3T34201.USD","WPP","LU0320765992.SGD","BK4551","BK4528","BK7104","BK4139"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623797349","title":"Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2623797349","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623797349?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:44","pubTimestamp":1774881840,"startTime":"0","endTime":"0","summary":"Pharmaceutical stocks are drawing renewed attention as investors look for areas of the market that can hold up in a more uncertain environment. As volatility increases and growth expectations become less clear, the sector's steady demand, resilient earnings, and less sensitivity to the economic cycle are starting to stand out.The VanEck Pharmaceutical ETF is up 11% over the past year and down 2% year to date compared with the State Street Healthcare Select Sector SPDR ETF, which is down more than 7% in 2026. The PPH pharma ETF is a bit illiquid, but provides a good visual representation of the sector's outperformance.GSK, a global diversified pharmaceutical maker, satisfies those looking for international exposure. The stock is up 10% year to date, 39% over the past year, and pays a dividend yield of 3.3%. A 13% haircut from mid February offers a good risk/reward setup here in my opinion. A well received acquisition in January should help","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2168564065.EUR","SGXZ99366536.SGD","IE00BWXC8680.SGD","LU0456855351.SGD","LU0820562030.AUD","IE0004445239.USD","LU2237443895.HKD","LU2456880835.USD","SG9999015945.SGD","LU1894683264.USD","LU2168564149.EUR","LU2471134796.USD","LU1917777945.USD","LU2756315318.SGD","LU1023059063.AUD","LU0385154629.USD","LU0823434583.USD","LU1093756325.SGD","LU0786609619.USD","LU2089284900.SGD","LU0353189680.USD","PFE","LU2552382132.HKD","LU2028103732.USD","IE00BJJMRZ35.SGD","LU1883839398.USD","LU0061475181.USD","IE00BFSS7M15.SGD","IE00BLSP4239.USD","LU2896262040.SGD","LU0256863902.USD","LU1551013342.USD","LU0787776722.HKD","LU1623119135.USD","IE00BKPKM429.USD","LU1035775433.USD","LU2236285917.USD","LU0225771236.USD","ELIS","LU2111349929.HKD","LU0820561909.HKD","BK4533","IE00B1XK9C88.USD","LU0882574055.USD","SG9999002232.USD","SG9999002224.SGD","LU0266013472.USD","LU0170899867.USD","LU0466842654.USD","LU0096364046.USD","LU2602419157.SGD","IE0009355771.USD","LU1548497426.USD","LU2237443978.SGD","LU2471134523.USD","IE00BBT3K403.USD","LU2213496289.HKD","LU1988902786.USD","LU1983299246.USD","LU0109394709.USD","LU1066053197.SGD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU2168564222.USD","LU2265009873.SGD","BK4588","LU2237443382.USD","IE00BJJMRY28.SGD","LU0683600562.USD","NVOX","LU0122379950.USD","LU1323610961.USD","LU1069344957.HKD","LU0354030438.USD","LU0672654240.SGD","SG9999011175.SGD","LU0320765059.SGD","LU0006306889.USD","SG9999015952.SGD","LU0882574139.USD","LU0689472784.USD","LU2087625088.SGD","LU1894683348.USD","IE00BFSS8Q28.SGD","LU0964807845.USD","IE00BJLML261.HKD","LU0225283273.USD","LU2324357040.USD","LU2106854487.HKD","LU1814569148.SGD","LU0889565916.HKD","IE00BKVL7J92.USD","LU2357305700.SGD","IE00BN29S564.USD","LU1720051017.SGD","LU1057294990.SGD","LU1989771016.USD","GSK","LU1551013425.SGD","LU2462157665.USD","IE00B4R5TH58.HKD","LU2361044949.HKD","LU0820561818.USD","LU2471134952.CNY","LU0320765992.SGD","LU2552382058.USD","LU2471134879.HKD","LU2750360997.AUD","LU1829250122.USD","IE0005OL40V9.USD","LU0306806265.USD","IE00B4JS1V06.HKD","LU0354030511.USD","LU0203202063.USD","LU0823434740.USD","LU1291159041.SGD","LU0321505439.SGD","SG9999003800.SGD","IE00B1BXHZ80.USD","LU0225284248.USD","LU1868837136.USD","SGXZ51526630.SGD","LU2746668461.USD","GB00BDT5M118.USD","LU0943347566.SGD","BK4568","LU1061106388.HKD","LU0289739699.SGD","LLYX","BK4592","GSKH","IE00B7KXQ091.USD","LU0708995401.HKD","LU2089283258.USD","LU2417539215.USD","LU1868836591.USD","BK4585","IE00BK4W5L77.USD","IE000M9KFDE8.USD","LU1232071149.USD","LU1974910355.USD","BK4550","LU0154236417.USD","LU2023251221.USD","LU0158827781.USD","LU2264538146.SGD","BK4007","SG9999018865.SGD","IE0001KFT4U8.USD","LU0471298694.HKD","BK4534","LU2112291526.USD","SG9999001176.SGD","IE00BKDWB100.SGD","LU2237443622.USD","SG9999014898.SGD","LU1145028129.USD","LU2491050071.SGD","BK4581","LU1868836757.USD","SG9999014906.USD","IE0002270589.USD","LU1868837300.USD","SG9999001176.USD","LU0094547139.USD","LU0058720904.USD","BK4599","FDN","LU2237443549.SGD","LU2750360641.GBP","LU1804176565.USD","LU0868494617.USD","LU1868836914.USD","SG9999015978.USD","LLYZ","SGXZ31699556.SGD","LU0471298777.SGD","IE00BZ1G4Q59.USD","SG9999013999.USD","SG9999017495.SGD","LU0417517546.SGD","LU0203201768.USD","LU0114720955.EUR","IE00B19Z3581.USD","NVOH","LU0210536198.USD","LU0256863811.USD","LU2108987350.USD","IE00B2B36J28.USD","LU0353189763.USD","LU0234572021.USD","LU1064131342.USD","SG9999014880.SGD","LU2089984988.USD","LU1712237335.SGD","LU0106261372.USD","LU2211815571.USD","LU0321505868.SGD","SGXZ57979304.SGD","LU1127390331.HKD","LU0640476718.USD","IE0004445015.USD","IE0002141913.USD","IE00BLSP4452.SGD","BK4516","LU0323591593.USD","LU1629891620.HKD","SG9999015986.USD","LU1267930730.SGD","SG9999018857.SGD","ELIL","LU2063271972.USD","BK4532","LLII","LU0823416689.USD","LU2361044865.SGD","LU0306807586.USD","LU2491050154.USD","LU2552382215.SGD","LU2168563687.JPY","LU0097036916.USD","LU1066051498.USD","LU2023250330.USD","LU2237443465.HKD","LU1720051108.HKD","GSK.UK","LU2461242641.AUD","IE00BK4W5M84.HKD","SG9999014914.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU0316494557.USD","LU2360106947.USD","LU0985481810.HKD","LU2271345857.HKD","LU1093756168.USD","LU2746668974.SGD","SGXZ81514606.USD","LU0158827948.USD","IE00B19Z3B42.SGD","LU0079474960.USD","LU0238689110.USD","LU1280957306.USD","LU2237438978.USD","LU2756315664.SGD","LU2468319806.SGD","LU1366192091.USD","IE00B775H168.HKD","IE00BJJMRX11.SGD","LU0109391861.USD","LU2023250504.SGD","LU2491049909.HKD","LU2361045086.USD","LU2168564495.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623845349","title":"Novo Nordisk Details Progress in DKK 15 Billion Share Buyback Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2623845349","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623845349?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:15","pubTimestamp":1774880158,"startTime":"0","endTime":"0","summary":"Novo Nordisk ( ($NVO) ) has provided an announcement. Novo Nordisk, a leading Danish healthcare group specialising in treatments for serious chroni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-details-progress-in-dkk-15-billion-share-buyback-programme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4097","LU0154236417.USD","BK4588","LU1093756168.USD","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4550","LU2065732104.USD","BK4585","NVOX","NVOH","NVO","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623794312","title":"Novo Nordisk: Solid Wegovy Pill Uptake but Intensifying GLP‑1 Competition Keeps Shares at Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2623794312","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623794312?lang=en_us&edition=fundamental","pubTime":"2026-03-30 19:55","pubTimestamp":1774871736,"startTime":"0","endTime":"0","summary":"Novo Nordisk, the Healthcare sector company, was revisited by a Wall Street analyst on March 27. Analyst Evan Seigerman from BMO Capital maintained...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/novo-nordisk-solid-wegovy-pill-uptake-but-intensifying-glp‑1-competition-keeps-shares-at-hold-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/novo-nordisk-solid-wegovy-pill-uptake-but-intensifying-glp‑1-competition-keeps-shares-at-hold-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","IE00BKVL7J92.USD","BK4588","BK4585","BK4007","LU1093756325.SGD","NVO","XBI","NVOH","BK4144","BK4581","LU0154236417.USD","BK4590","BK4599","NVOX","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623151263","title":"Novo Nordisk Earnings Could Be Solid, but Consensus Still Too High -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2623151263","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623151263?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:59","pubTimestamp":1774864740,"startTime":"0","endTime":"0","summary":"0958 GMT - Novo Nordisk's first-quarter results could be solid, with a strong beat for the Wegovy treatment in oral form and a 2026 guidance reiteration, J.P. Morgan analysts write in a research note. \"Overall, we anticipate a solid set of results, slightly ahead of consensus on adjusted operating profit and adjusted EPS.\" However, the bank still thinks that consensus is significantly too high, particularly at the operating profit level. JPM says that a 5% cut to consensus is required just to get to the top-end of the Danish drugmaker's guidance range, so even with a strong oral Wegovy result it sees the potential for consensus numbers to come down following the results. Shares rise 0.6% to 229.80 Danish kroner. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","NVOH","BK4588","IE00BKVL7J92.USD","NVOX","LU1093756325.SGD","BK4585","LU0154236417.USD","BK4532","BK4007","LU1093756168.USD","NVO","BK4599"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2623399594","title":"J.P. Morgan Remains a Hold on Novo Nordisk (0QIU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623399594","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623399594?lang=en_us&edition=fundamental","pubTime":"2026-03-30 14:08","pubTimestamp":1774850915,"startTime":"0","endTime":"0","summary":"J.P. Morgan analyst Richard Vosser maintained a Hold rating on Novo Nordisk today and set a price target of DKK250.00. According to TipRanks, Vosse...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-hold-on-novo-nordisk-0qiu-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0320765646.SGD","LU2111349929.HKD","NVOX","LU0267386448.USD","LU2347655156.SGD","LU0154236417.USD","LU0912757837.SGD","BK4581","LU1093756325.SGD","LU1732800096.USD","LU2028103732.USD","BK4532","LU0006306889.USD","LU1244550577.SGD","LU1548497426.USD","LU0528227936.USD","LU2089284900.SGD","LU0098860793.USD","LU0234570918.USD","LU0795875086.SGD","BK4516","LU1720051108.HKD","LU2089283258.USD","LU1093756168.USD","LU0882574139.USD","LU0158827948.USD","BK4127","LU1363072403.SGD","LU1668664300.SGD","LU0971096721.USD","IE00BZ1G4Q59.USD","LU1244550221.USD","LU0795875169.SGD","LU2023251221.USD","LU1989772923.USD","BK4588","BK4599","LU0158827781.USD","LU1074936037.SGD","LU0106831901.USD","LU2357305700.SGD","NVO","LU2133065610.SGD","LU1791710400.SGD","LU1720051017.SGD","LU1732799900.SGD","LU0557290698.USD","BK4534","LU0106261372.USD","LU1162221912.USD","LU1244550494.USD","LU2271345857.HKD","IE00BKVL7J92.USD","NVOH","LU1791710582.SGD","BK4007","LU0225283273.USD","LU0314104364.USD","BK4504","LU1989772840.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}